AbCellera Biologics(ABCL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ABCL AbCellera Biologics

Closed 04-24 16:00:00 EDT

4.15

+0.10

+2.47%

盘后4.21

+0.06+1.45%

19:39 EDT

High4.29	Low3.97	Vol9.42M
Open4.08	D1 Closing4.05	Amplitude7.90%
Mkt Cap1.26B	Tradable Cap841.41M	Total Shares303.16M
T/O39.23M	T/O Rate4.64%	Tradable Shares202.75M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ABCL","market":"US","secType":"STK","nameCN":"AbCellera Biologics","latestPrice":4.15,"timestamp":1777060800000,"preClose":4.05,"halted":0,"volume":9417311,"hourTrading":{"tag":"盘后","latestPrice":4.21,"preClose":4.15,"latestTime":"19:39 EDT","volume":36506,"amount":153334.2304,"timestamp":1777073946007,"change":0.06,"changeRate":0.014458,"amplitude":0.021687},"delay":0,"changeRate":0.024691358024691492,"floatShares":202749853,"shares":303160487,"eps":-0.49,"marketStatus":"Closed","change":0.1,"latestTime":"04-24 16:00:00 EDT","open":4.08,"high":4.29,"low":3.97,"amount":39227573.537725,"amplitude":0.079012,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.49,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1777276800000},"marketStatusCode":5,"adr":0,"listingDate":1607662800000,"exchange":"NASDAQ","adjPreClose":4.05,"preHourTrading":{"tag":"盘前","latestPrice":4.08,"preClose":4.05,"latestTime":"09:29 EDT","volume":42379,"amount":173781.4590637,"timestamp":1777037341006,"change":0.03,"changeRate":0.007407,"amplitude":0.017086},"postHourTrading":{"tag":"盘后","latestPrice":4.21,"preClose":4.15,"latestTime":"19:39 EDT","volume":36506,"amount":153334.2304,"timestamp":1777073946007,"change":0.06,"changeRate":0.014458,"amplitude":0.021687},"volumeRatio":1.71763,"impliedVol":0.8894,"impliedVolPercentile":0.2789},"requestUrl":"/m/hq/s/ABCL","defaultTab":"news","newsList":[{"id":"2629310857","title":"A Look At AbCellera Biologics (ABCL) Valuation After Its Planned ABCL635 Phase 1 Data Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2629310857","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629310857?lang=en_us&edition=fundamental","pubTime":"2026-04-24 02:14","pubTimestamp":1776968054,"startTime":"0","endTime":"0","summary":"AbCellera Biologics (ABCL) has drawn fresh attention after announcing plans to share interim Phase 1 data for its menopause therapy candidate ABCL635 during its first quarter 2026 earnings call on May 11.\nSee our latest analysis for AbCellera Biologics.\nThe recent ABCL635 update comes after a mixed stretch for the stock, with a 21.07% 1 month share price return and 18.95% year to date share price return contrasting with a 12.07% 3 month decline. The 61.26% 1 year total shareholder return...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-abcl/abcellera-biologics/news/a-look-at-abcellera-biologics-abcl-valuation-after-its-plann","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-abcl/abcellera-biologics/news/a-look-at-abcellera-biologics-abcl-valuation-after-its-plann","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4535","BK4121","ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628725402","title":"Press Release: AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2628725402","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628725402?lang=en_us&edition=fundamental","pubTime":"2026-04-20 21:16","pubTimestamp":1776690960,"startTime":"0","endTime":"0","summary":"AbCellera  today announced that it will disclose interim results from the Phase 1 portion of its study of ABCL635, including observed safety profile, pharmacokinetic, and pharmacodynamic target engagement data, during its first quarter 2026 earnings call on Monday, May 11, 2026.ABCL635 is a potential first-in-class antibody therapeutic targeting the neurokinin 3 receptor  for the non-hormonal treatment of moderate-to-severe vasomotor symptoms  associated with menopause. It is currently being evaluated in a Phase 1/2 study, and the results of the ongoing multicenter, randomized, double-blind, placebo-controlled Phase 2 portion in postmenopausal women with moderate-to-severe VMS are anticipated in Q3 2026.As previously announced, AbCellera will host its first quarter 2026 earnings call on Monday, May 11, 2026 at 2:00 p.m. PT . A live audio webcast of the earnings conference may be accessed through a link that will be posted on AbCellera's Investor Relations website. A replay will be avai","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GPCR","BK4599","BK4535","ABCL","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628255757","title":"AbCellera updates financial calendar with upcoming quarterly earnings call","url":"https://stock-news.laohu8.com/highlight/detail?id=2628255757","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628255757?lang=en_us&edition=fundamental","pubTime":"2026-04-20 21:01","pubTimestamp":1776690088,"startTime":"0","endTime":"0","summary":"AbCellera scheduled first-quarter 2026 earnings call for May 11, 2026 at 2:00 p.m. PT.Call will include interim Phase 1 data readout for ABCL635.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abcellera Biologics Inc. published the original content used to generate this news brief via Business Wire  on April 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL6z2pgP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4535","ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627284519","title":"Analysts Offer Insights on Healthcare Companies: AbCellera Biologics (ABCL), Telix Pharmaceuticals (OtherTLPPF) and Johnson & Johnson (JNJ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627284519","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627284519?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:21","pubTimestamp":1776255689,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbCellera Biologics (ABCL), Telix Pharmaceuticals (T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abcellera-biologics-abcl-telix-pharmaceuticals-othertlppf-and-johnson-johnson-jnj-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abcellera-biologics-abcl-telix-pharmaceuticals-othertlppf-and-johnson-johnson-jnj-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2471134952.CNY","LU1244550221.USD","IE000F7OJYX1.SGD","LU1718418525.SGD","LU0882574055.USD","LU0683600562.USD","IE000BZT7R73.USD","LU2129689514.USD","XBI","LU2347655156.SGD","SG9999002224.SGD","IE00BFTCPJ56.SGD","LU0345769631.USD","LU0889566641.SGD","LU1061106388.HKD","LU2592432038.USD","LABU","LU0432979614.USD","XLV","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU0203345920.USD","BK4139","IE00BFXG1179.USD","LU1043141396.HKD","LU0098860793.USD","LU2505996681.GBP","LU0029874061.USD","LU1267930813.SGD","ABCL","LU1221951046.USD","HCSG","LU1935042991.SGD","BK4559","BK4533","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU1057294990.SGD","IE00BLSP4452.SGD","TLX","LU1066051498.USD","SGXZ57979304.SGD","IE000SO60NU8.SGD","IE00B19Z3581.USD","LU0426412945.USD","LU1244550494.USD","BK4568","LU0234570918.USD","LU1261432733.SGD","JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627464489","title":"How Investors Are Reacting To AbCellera Biologics (ABCL) After New Jones Trading Coverage Initiation","url":"https://stock-news.laohu8.com/highlight/detail?id=2627464489","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627464489?lang=en_us&edition=fundamental","pubTime":"2026-04-13 11:25","pubTimestamp":1776050712,"startTime":"0","endTime":"0","summary":"Earlier this week, Jones Trading initiated coverage on AbCellera Biologics, assigning the company a new rating and highlighting its antibody-medicine pipeline in various stages of clinical development.\nThis fresh analyst attention brings renewed focus to AbCellera’s transition toward clinical-stage programs and its efforts to address unmet medical needs with antibody therapies.\nWe’ll now explore how Jones Trading’s new coverage initiation interacts with AbCellera’s existing investment...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-abcl/abcellera-biologics/news/how-investors-are-reacting-to-abcellera-biologics-abcl-after","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-abcl/abcellera-biologics/news/how-investors-are-reacting-to-abcellera-biologics-abcl-after","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4121","ABCL","BK4535","BK4211","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626190820","title":"AbCellera Biologics Initiated at Buy by Jones Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2626190820","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626190820?lang=en_us&edition=fundamental","pubTime":"2026-04-10 20:30","pubTimestamp":1775824200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ABCL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 10, 2026 08:30 ET (12:30 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ABCL","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626130198","title":"AbCellera initiated with a Buy at JonesResearch","url":"https://stock-news.laohu8.com/highlight/detail?id=2626130198","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626130198?lang=en_us&edition=fundamental","pubTime":"2026-04-10 04:10","pubTimestamp":1775765426,"startTime":"0","endTime":"0","summary":"JonesResearch analyst Debanjana Chatterjee initiated coverage of AbCellera (ABCL) with a Buy rating and $11 price target AbCellera’s validated anti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abcellera-initiated-with-a-buy-at-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abcellera-initiated-with-a-buy-at-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","BK4121","ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625676082","title":"AbCellera Biologics (ABCL) Receives a Buy from Truist Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2625676082","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625676082?lang=en_us&edition=fundamental","pubTime":"2026-04-06 19:35","pubTimestamp":1775475341,"startTime":"0","endTime":"0","summary":"Truist Financial analyst Srikripa Devarakonda reiterated a Buy rating on AbCellera Biologics today and set a price target of $3.52. According to Ti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/abcellera-biologics-abcl-receives-a-buy-from-truist-financial-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/abcellera-biologics-abcl-receives-a-buy-from-truist-financial-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4535","ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624953549","title":"AbCellera schedules first-quarter earnings release, conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2624953549","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624953549?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:05","pubTimestamp":1775073920,"startTime":"0","endTime":"0","summary":"AbCellera schedules first-quarter fiscal 2026 financial results for May 11, 2026.Earnings conference call set for May 11, 2026 at 2:00 p.m. PT .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL7wWYXR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ABCL","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624640518","title":"3 Penny Stocks With Market Caps Under $19B To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2624640518","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624640518?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:05","pubTimestamp":1775041506,"startTime":"0","endTime":"0","summary":"The market remained flat over the last week, but it is up 16% over the past year, with earnings expected to grow by 15% annually in the coming years. For those interested in smaller or newer companies, penny stocks—despite their somewhat outdated name—can still offer surprising value and potential for growth. By focusing on stocks with strong financial foundations, investors may find opportunities that combine stability with promising prospects.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3242000-choice1-main-header/1585186612362","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3242000-choice1-main-header/1585186612362"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/transportation/otc-didi.y/didi-global/news/3-penny-stocks-with-market-caps-under-19b-to-watch","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/transportation/otc-didi.y/didi-global/news/3-penny-stocks-with-market-caps-under-19b-to-watch","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FINV","BK4531","BK4576","BK4579","BK4526","BK4535","BK4142","BK4134","BK4183","BK4508","ABCL","BK4505","BK4122","BK4023","TUYA","BK4076","LX","BK4191","III","CRCT","NAGE","BK4539","BK4121","LU1235295612.USD","LU1046422090.SGD","BK4554","LFVN","RERE","BK4551","BK4503","BK4166","LU0049112450.USD","BK4077","TOUR","BK4509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618593908","title":"A Look At AbCellera Biologics (ABCL) Valuation After Annual Earnings Reveal Higher Revenue And A Narrower Net Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2618593908","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618593908?lang=en_us&edition=fundamental","pubTime":"2026-03-10 17:17","pubTimestamp":1773134266,"startTime":"0","endTime":"0","summary":"AbCellera Biologics (ABCL) is back in focus after releasing full year 2025 results, reporting revenue of US$75.13 million compared with US$28.83 million a year earlier and a net loss of US$146.41 million compared with US$162.86 million.\nSee our latest analysis for AbCellera Biologics.\nAbCellera Biologics’ latest earnings drop comes after a mixed period for investors, with a 1-month share price return of 11.39% but a 3-year total shareholder return decline of 52.56% and a 5-year total...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-abcl/abcellera-biologics/news/a-look-at-abcellera-biologics-abcl-valuation-after-annual-ea","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-abcl/abcellera-biologics/news/a-look-at-abcellera-biologics-abcl-valuation-after-annual-ea","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616439967","title":"Major Investor Quietly Ramps Up Stake in AbCellera Biologics","url":"https://stock-news.laohu8.com/highlight/detail?id=2616439967","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616439967?lang=en_us&edition=fundamental","pubTime":"2026-03-03 10:07","pubTimestamp":1772503635,"startTime":"0","endTime":"0","summary":"New insider activity at AbCellera Biologics ( ($ABCL) ) has taken place on March 2, 2026. Significant shareholder Thermopylae Holdings Ltd. has boo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-ramps-up-stake-in-abcellera-biologics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-ramps-up-stake-in-abcellera-biologics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABCL","BK4535","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116759654","title":"Stock Track | AbCellera Biologics Soars 5.26% Intraday on Major Shareholder Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=1116759654","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116759654?lang=en_us&edition=fundamental","pubTime":"2026-03-03 04:50","pubTimestamp":1772484640,"startTime":"0","endTime":"0","summary":"AbCellera Biologics' stock surged 5.26% during intraday trading on Monday, following news of increased ownership by a significant investor.The price movement appears to be driven by a filing...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614989901","title":"Insiders Quietly Double Down on AbCellera Biologics in Bold Buying Spree","url":"https://stock-news.laohu8.com/highlight/detail?id=2614989901","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614989901?lang=en_us&edition=fundamental","pubTime":"2026-02-28 10:07","pubTimestamp":1772244458,"startTime":"0","endTime":"0","summary":"New insider activity at AbCellera Biologics ( ($ABCL) ) has taken place on February 27, 2026. AbCellera Biologics has seen notable insider buying a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/insiders-quietly-double-down-on-abcellera-biologics-in-bold-buying-spree-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/insiders-quietly-double-down-on-abcellera-biologics-in-bold-buying-spree-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","BK4121","SHAP.U","ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127244178","title":"Stock Track | AbCellera Biologics Soars 5.26% in After-Hours on Insider Buying by Major Shareholder and CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=1127244178","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127244178?lang=en_us&edition=fundamental","pubTime":"2026-02-28 07:54","pubTimestamp":1772236484,"startTime":"0","endTime":"0","summary":"AbCellera Biologics' stock surged 5.26% in the after-hours session on Friday, following significant insider purchases reported earlier in the day.The movement appears to be driven by filings showing...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614867803","title":"Thermopylae Holdings Ltd. Acquires AbCellera Biologics Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2614867803","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614867803?lang=en_us&edition=fundamental","pubTime":"2026-02-28 05:28","pubTimestamp":1772227687,"startTime":"0","endTime":"0","summary":"Thermopylae Holdings Ltd., a 10% owner, reported an acquisition of 177,457 common shares of AbCellera Biologics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abcellera Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nNDL9lkG8l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4121","ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614786103","title":"AbCellera CFO Andrew Booth Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2614786103","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614786103?lang=en_us&edition=fundamental","pubTime":"2026-02-28 03:49","pubTimestamp":1772221754,"startTime":"0","endTime":"0","summary":"Andrew Booth, Chief Financial Officer, reported an acquisition of common shares of AbCellera Biologics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abcellera Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nNDL2fmzBs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AbCellera CFO Andrew Booth Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ABCL","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614099694","title":"Abcellera Warns Growing Generative AI Use Raises Cybersecurity, Privacy, and Operational Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2614099694","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614099694?lang=en_us&edition=fundamental","pubTime":"2026-02-26 14:00","pubTimestamp":1772085648,"startTime":"0","endTime":"0","summary":"Abcellera Biologics, Inc. (ABCL) has disclosed a new risk, in the Cyber Security category. Abcellera Biologics, Inc. faces growing risk as it and i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abcellera-warns-growing-generative-ai-use-raises-cybersecurity-privacy-and-operational-risks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abcellera-warns-growing-generative-ai-use-raises-cybersecurity-privacy-and-operational-risks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","ABCL","NTSK","BK4097","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614230065","title":"AbCellera (ABCL) Earnings Call: Liquidity, Risks, Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2614230065","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614230065?lang=en_us&edition=fundamental","pubTime":"2026-02-26 08:26","pubTimestamp":1772065584,"startTime":"0","endTime":"0","summary":"Abcellera Biologics, Inc. (($ABCL)) has held its Q4 earnings call. Read on for the main highlights of the call. AbCellera Biologics’ latest earning...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abcellera-abcl-earnings-call-liquidity-risks-catalysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abcellera-abcl-earnings-call-liquidity-risks-catalysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614035340","title":"Abcellera Biologics Inc : Piper Sandler Cuts Target Price to $12 From $16","url":"https://stock-news.laohu8.com/highlight/detail?id=2614035340","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614035340?lang=en_us&edition=fundamental","pubTime":"2026-02-25 22:40","pubTimestamp":1772030449,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nFWN3ZL1SE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","BK4535","ABCL"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abcellera.com","stockEarnings":[{"period":"1week","weight":0.0574},{"period":"1month","weight":0.2236},{"period":"3month","weight":-0.0448},{"period":"6month","weight":-0.2845},{"period":"1year","weight":0.6008},{"period":"ytd","weight":0.1842}],"compareEarnings":[{"period":"1week","weight":0.0097},{"period":"1month","weight":0.0846},{"period":"3month","weight":0.0279},{"period":"6month","weight":0.0461},{"period":"1year","weight":0.3232},{"period":"ytd","weight":0.0389}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. It has a research collaboration and license agreement with Eli Lilly and Company; and a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.002724},{"month":2,"riseRate":0,"avgChangeRate":-0.119779},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.059327},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.06068},{"month":5,"riseRate":0.6,"avgChangeRate":-0.032152},{"month":6,"riseRate":0.4,"avgChangeRate":0.119513},{"month":7,"riseRate":0.6,"avgChangeRate":0.046684},{"month":8,"riseRate":0.4,"avgChangeRate":-0.080936},{"month":9,"riseRate":0.6,"avgChangeRate":0.036664},{"month":10,"riseRate":0.6,"avgChangeRate":0.00539},{"month":11,"riseRate":0.6,"avgChangeRate":-0.007841},{"month":12,"riseRate":0.2,"avgChangeRate":-0.030878}],"exchange":"NASDAQ","name":"AbCellera Biologics","nameEN":"AbCellera Biologics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"AbCellera Biologics(ABCL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest AbCellera Biologics(ABCL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"AbCellera Biologics,ABCL,AbCellera Biologics股票,AbCellera Biologics股票老虎,AbCellera Biologics股票老虎国际,AbCellera Biologics行情,AbCellera Biologics股票行情,AbCellera Biologics股价,AbCellera Biologics股市,AbCellera Biologics股票价格,AbCellera Biologics股票交易,AbCellera Biologics股票购买,AbCellera Biologics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"AbCellera Biologics(ABCL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest AbCellera Biologics(ABCL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction